Peripartum Cardiomyopathy Paul M. Johnson Department of Internal Medicine University of North...
-
date post
19-Dec-2015 -
Category
Documents
-
view
219 -
download
2
Transcript of Peripartum Cardiomyopathy Paul M. Johnson Department of Internal Medicine University of North...
Peripartum Cardiomyopathy
Paul M. JohnsonDepartment of Internal Medicine
University of North Carolina HospitalsNovember 11, 2009
Overview
• Defining PPCM• Incidence• Etiology• Diagnosis• Treatment• Prognosis
• Our patient today…• Key Points
http://www.e-heart.org/Pages/03_Cardiomyopathy/03_Cardiomyopathy_DCM_001.htm
How to define PPCM
• NHLBI Workshop on Peripartum Cardiomyopathy (2000)– development of heart failure in the last month of
pregnancy or five months after delivery– no pre-existing heart disease– no determinable cause of cardiomyopathy– LV systolic dysfunction defined by LVEF <45% or
reduced shortening fraction (30% on M-mode)
JAMA 2000; 283: 1183-8
Incidence “These Hausa-Fulani women eat large quantities of a local lake salt, kanwa, for 40 days postpartum. The syndrome is markedly more common in the hot rainy season, when
evaporative water loss is less, than in the dry season. The first postpartum days are spent confined to bed in a small heated room. Once or twice daily the new mother is given hot baths with branches which have been dipped in boiling water. The combination of excessive sodium intake and diminished evaporative water excretion seems to precipitate failure in both
normotensive and hypertensive patients.”- Circulation. 1977; 56: 1058-1061
Incidence of PPCM• Reported incidence is highly variable– Nigeria
• among the Hausa in Zaria, as high as 1 per 100 live births• up to 13% of hospital admissions for females
– Haiti• 1 per 300 live births
– South Africa• 1 per 1000
– United States• between 1 per 3000 to 1 per 4000 live births• about 1300 women per year, mortality of up to 5%• a reported geographic predilection for Southern states
Int J Cardiol 2007; 118: 295-303
Risk factors for PPCM
• advanced age >30• multiparity• African descent• multiple gestation• obesity• preeclampsia/eclampsia• hypertension• prolonged (>4 weeks) tocolysis with beta agonists
• risk factors remain poorly understood
Int J Cardiol 2007; 118: 295-303
Etiology, in other words
• most cases are idiopathic• myocarditis– predisposition to more severe forms of viral myocarditis
(8.8% - 76% prevalence)• autoimmune– fetal antigen
response– chimerism
• hemodynamic– inc blood volume– inc cardiac outputLancet 2006; 368: 687–93
Diagnosis• DOE, fatigue, pedal edema can
be normal in pregnancy• Be aware of warning signs – PND, crackles, JVD
• CXR– cardiomegaly, edema, pleural
effusions
• EKG– normally NSR, but occasionally
LVF, TWIs, Q wave
• Must have ECHO for diagnosis
Treatment of PPCM• Similar to other types of CHF
– optimize hemodynamics– relief of symptoms– chronic therapies that improve long-term outcomes
• Specifically– avoid ACEI in pregnancy (OK in breast feeding)– use of hydralazine, digoxin acceptable
• Anticoagulation– consider in LVEF <30%
• Transplant– 4-7% of patients– successful pregnancies after transplant
• Immunosuppression in myocarditis-mixed results, never empirically
Prognosis• prognosis related to related to LV recovery• 50% recover baseline function within 6 months
www.uptodate.com from Felker et. al. N Engl J Med 2000; 342: 1077
Prognosis-another pregnancy?• Recovered LV function– 28 women– LVEF decreased 20% in 6
women – 6 women got HF– no deaths
• Persistent LV dysfunction– 16 women– three deaths– HF in 7 patients– premature delivery in 6,
therapeutic abortion in four
Lancet 2006; 368: 687–93
NEJM 2001; 344: 1567
Our patient today…
• admitted to cardiology with sore throat and TWI on EKG five days ago
• diagnosed with strep throat and discharged with amoxicillin x 10 days
• ECHO showed EF 50-55%
Key Points
• PPCM diagnosed in 1 per 3000 to 4000 births/year
• Etiology is likely multifactorial, and still unclear• Set diagnostic criteria– no previous disease, no other cause– onset one month before, five months after birth– LVEF < 45%
• 50% regain normal LVEF, 50% do not• No guidelines for subsequent pregnancies
References• Abboud, J, et. al. Peripartum cardiomyopathy: A comprehensive
review. Int J of Cardiol 2007; 118: 295-303.• Bales, AC, and Lang, RM. Peripartum cardiomyopathy. Accessed
11/10/09 at www.uptodate.com• Elkayam, U, et. al. Maternal and fetal outcomes of subsequent
pregnancies in women with peripartum cardiomyopathy. NEJM 2001; 344: 1567
• Fillmore, SJ, and Perry, EH. The evolution of peripartal heart failure in Zaria, Nigeria. Some etiologic factors. Circulation. 1977;56:1058-1061
• Rhamaraj, R, and Sorrell, VL. Peripartum cardiomyopathy: causes, diagnosis, and treatment. Clev Clin J Med. 2009; 76: 289-296
• Sliwa, K, et. al. Peripartum cardiomyopathy. Lancet. 2006 Aug 19;368(9536):687-93.